Allogene Therapeutics
World Rank (Jan-05-2024)
11,801
Market Cap (Jan-05-2024)
0.570 Billion USD
World Rank (Jul-30-2023)
10,537
Market Cap (Jul-30-2023)
0.718 Billion USD
World Rank (Dec-25-2022)
9,189
Market Cap (Dec-25-2022)
0.859 Billion USD
World Rank (Jan-07-2022)
6,446
Market Cap (Jan-07-2022)
1.92 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-332 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
Allogene Therapeutics is a Clinical Stage Biotechnology company. It single minded focus on pioneering the development of allogeneic chimeric antigen receptor T cell therapies for cancer and researchers is dedicated to discovery and translational research, development and cell manufacturing. The headquarters is in USA.
Company Website